Take advantage of Rossix know how in your research and product development.

Our highly stable phospholipid emulsions are suitable for use in analyses related to procoagulant and anticoagulant pathways.

Founders

Per Rosén

Managing Director

per.rosen@rossix.com

Apart from being the Managing Director, Per is involved on a daily basis in:

General Operations

R&D

Contract Analysis

Per has a Master of Science in Bio Engineering (2006) and a Bachelor of Science in Business Administration (2006).

He did his Master Thesis "Experimental Design in Assay Development" at AstraZeneca R&D in Mölndal, Sweden where he worked at the High Throughput Screening (HTS) department with assay development. He continued to work at this department after completed studies. Thereafter, Per worked during one year as a Purchasing Analyst at AstraZeneca Purchasing in Södertälje, Sweden.

In 2007 Per joined Steffen to work at Rossix and were appointed Managing Director when Rossix AB was founded in Jan 2011.

Pia Bryngelhed

Director Quality Control

pia.bryngelhed@rossix.com

Pia is involved on a daily basis in:

Quality Control

General Operations

R&D

Contract Analysis

Pia has a Degree of Master of Medicine in Pharmaceutical Bioscience (2007).

She did her Master Thesis “NAG excretion from the kidneys in a healthy population” at the department of Occupational and Environmental Medicine at Gothenburg University, Sweden.

Steffen Rosén

Director Scientific and Medical Affaris

steffen.rosen@rossix.com

Steffen Rosén has a background as PhD in biochemistry and started his career at Kabi Diagnostica 1978. He expanded the bioreagent purification and was responsible for the development of Coatest Factor VIII, the first chromogenic FVIII kit. He became head of coagulation research and later Director R&D and VP Scientific and Medical Affairs at Chromogenix.

Under his guidance, several chromogenic kits in coagulation and fibrinioysis were developed as well as the clotting based Coatest APC Resistance Kit. Steffen was also the technical expert in patent matters at Chromogenix.

Steffen Rosén has more than 30 years experience from his work at Kabi Diagnostica and later Chromogenix in development of methods and products in Hemostasis.

In 2000 Steffen founded the company Rossix.

News

2012-03-23 Package Inserts and SDS

Package Inserts and Safety Data Sheets have been added to the product pages.

2012-03-01 Change Notification - Rox Factor IX

Substitution of bovine Factor XIa with human Factor XIa in Reagent B.

2011-08-22 Miniprint Rox Factor IX Poster - ISTH 2011

Check out the miniprint of the poster:

"Features of a new chromogenic kit for determination of FIX activity in plasma and FIX concentrates":

2011-07-05 ISTH 2011 - Kyoto, July 23-28

Pia Bryngelhed, Rossix, will present a poster about the features of the Rox Factor IX kit. Poster No P-TH-208.

Take the opportunity to meet us in Kyoto on July 28!

2011-01-01 Rossix - Rossix AB

In Jan 01, 2011, Rossix (sole proprietorship) was turned into a limited company, Rossix AB. As a consequense, the Corporate identity No,

VAT No and IBAN No has been changed.

2010-10-29 Lecture - Factor VIII:C assays

Steffen Rosén, Rossix gave a lecture on the topic Factor VIII:C assays at the Annual National Haemophilia Symposium in Hamburg, Germany 12-13th Nov 2010.

Rossix AB	Phone	+46 (0)31 706 8965	Copyright ©2011 Rossix
Taljegårdsgatan 4B	Fax	+46 (0)31 706 8966
S-431 53 Mölndal	E-mail	info@rossix.com
Sweden